New York City, NY – According to filings with the U.S. Securities and Exchange Commission, Conversion Labs is raising $3,500,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Justin Schreiber played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Conversion Labs

We are applying our direct response marketing expertise to healthcare and providing a convenient, cost-effective and smarter way for consumers to access high quality OTC products and prescription medications. Conversion Labs is an emerging leader in technology driven healthcare. We’re applying our direct-to-consumer marketing expertise to make access to high quality prescription medications and OTC products convenient, cost-effective, and simple. Our brands are intensely focused on our consumers, constantly striving to deliver a better end-to-end healthcare experience through technology. Our mission is to create and sell amazing products that improve the health and happiness of our customers.

To learn more about Conversion Labs, visit http://conversionlabs.com/

Contact:
Justin Schreiber, Chief Executive Officer
866-351-5907
https://www.linkedin.com/in/justinschreiber/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved